ScreenerHero

CINPHA Cinclus Pharma Holding AB (publ)

STO · SE · Healthcare · Drug Manufacturers - Specialty & Generic · cincluspharma.com
13.34SEK+3.09%Mkt Cap: 57.60M $P/E: —

Cinclus Pharma Holding AB (publ), a clinical-stage pharmaceutical company, develops small molecules for the treatment of gastric acid-related diseases in China. The company's lead product is linaprazan glurate, a potassi…

Industry Peers

Drug Manufacturers - Specialty & Generic
Screen all
MRK
Merck KGaA
$64.30BUSDP/E 25.0
TAK
Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)
$57.06BUSD
TEVA
Teva Pharmaceutical Industries Limited Ordinary Shares
$46.10BUSDP/E 65.9
HLN
Haleon plc American Depositary Shares (Each representing two Ordinary Shares)
$38.70BUSDP/E 18.3
ZOE
Zoetis Inc.
$28.27BUSDP/E 12.1
ZTS
Zoetis Inc. Class A Common Stock
$28.80BUSDP/E 11.4
UTHR
United Therapeutics Corporation - Common Stock
$23.23BUSDP/E 19.4
VTRS
Viatris Inc. - Common Stock
$20.22BUSD
SOBI
Swedish Orphan Biovitrum AB
$14.24BUSDP/E 109.4
NBIX
Neurocrine Biosciences, Inc. - Common Stock
$14.55BUSDP/E 21.0
IPN
Ipsen S.A.
$12.60BUSDP/E 22.8
ELAN
Elanco Animal Health Incorporated Common Stock
$11.06BUSD
RDY
Dr. Reddy's Laboratories Ltd Common Stock
$10.20BUSDP/E 29.2
KRK
Krka, d. d.
$8.50BUSDP/E 18.4
AMRX
Amneal Pharmaceuticals, Inc. - Class A Common Stock
$7.07BUSDP/E 42.3
ALKS
Alkermes plc - Ordinary Shares
$7.00BUSDP/E 109.9
HIMS
Hims & Hers Health, Inc. Class A Common Stock
$6.77BUSD
LNTH
Lantheus Holdings, Inc. - Common Stock
$6.53BUSDP/E 23.9
KNSA
Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares
$5.83BUSDP/E 76.6
INDV
Indivior Pharmaceuticals, Inc. - Common Stock
$4.21BUSDP/E 12.8

Key Statistics

Company
Market Cap57.60M USD
Enterprise Value25.73M USD
Revenue (TTM)3.36M USD
Gross Profit3.36M USD
Net Income (TTM)-17.60M USD
Revenue/Share0.69 SEK
Last Price13.34 SEK
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees17
CountrySE
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINSE0020388577
Valuation
P/E (Trailing)—
P/E (Forward)-2.29
PEG—
EV/EBITDA-0.93
EV/Revenue7.65
P/S17.12
P/B2.97
EPS (TTM)-5.78
EPS (Forward)—
52W Range
10.6030% of range19.64
52W High19.64 SEK
52W Low10.60 SEK
Profitability
Gross Margin100.00%
Oper. Margin-5381.14%
EBITDA Margin0.00%
Profit Margin-320.12%
ROE-49.80%
ROA-33.66%
Growth
Revenue Growth-94.80%
Earnings Growth—
Cash Flow & Leverage
Operating CF-7.14M USD
CapEx (TTM)108.47K USD
FCF Margin-353.33%
FCF Yield-20.64%
Net Debt-31.88M USD
Net Debt/EBITDA1.15
Balance Sheet
Debt/Equity0.02
Current Ratio2.30
Quick Ratio2.17
Book Value/Sh4.36 SEK
Cash/Share8.34 SEK
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 SEK
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.0 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)45.25 SEK
Upside (mean)+239.2%
Target Range25.00 SEK – 70.00 SEK
25.00+239.2% to mean70.00
# Analysts4
Ownership
Shares Out.46.54M
Float34.29M
Insiders29.95%
Institutions36.41%
Technical
SMA 5012.38 (+7.7%)
SMA 20014.34 (-7.0%)
Beta-0.03
S&P 52W Chg14.58%
Avg Vol (30d)56.74K
Avg Vol (10d)58.86K
Technical Indicators
RSI (14)58.9
MACD0.0921
MACD Signal-0.0678
MACD Hist.+0.1599
BB Upper13.32 SEK
BB Middle12.18 SEK
BB Lower11.04 SEK
BB Width18.68%
ATR (14)0.6465 SEK
Vol Ratio (20d)2.07x